Experimental stem cells tested as lifeline for COVID lung failure
NCT ID NCT04615429
Summary
This study tested whether stem cells from donors could help patients with severe COVID-19 lung failure. Twenty hospitalized patients were randomly assigned to receive either the stem cell treatment or a placebo, along with standard hospital care. Researchers measured whether the treatment improved patients' breathing and recovery over 28 days and tracked their health for a full year.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Universitario Puerta de Hierro-Majadahonda
Majadahonda, Madrid, 28222, Spain
Conditions
Explore the condition pages connected to this study.